285 related articles for article (PubMed ID: 19147994)
21. The relationship between transforming growth factor-beta1, vascular endothelial growth factor, nitric oxide and Hashimoto's thyroiditis.
Vural P; Degirmencioglu S; Erden S; Gelincik A
Int Immunopharmacol; 2009 Feb; 9(2):212-5. PubMed ID: 19028605
[TBL] [Abstract][Full Text] [Related]
22. Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients.
Ivanović V; Demajo M; Krtolica K; Krajnović M; Konstantinović M; Baltić V; Prtenjak G; Stojiljković B; Breberina M; Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Dimitrijević B
Clin Chim Acta; 2006 Sep; 371(1-2):191-3. PubMed ID: 16650397
[TBL] [Abstract][Full Text] [Related]
23. Measurement of urinary TGF-β1 in patients with diabetes mellitus and normal controls.
Tsapenko MV; Nwoko RE; Borland TM; Voskoboev NV; Pflueger A; Rule AD; Lieske JC
Clin Biochem; 2013 Oct; 46(15):1430-5. PubMed ID: 23685222
[TBL] [Abstract][Full Text] [Related]
24. [Association between TGF-Beta1 in allograft and chronic allograft nephropathy].
Wang PX; Fan MQ; Gong GZ; Xu HY; Huang CB; Zhang GT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):112-4, 122. PubMed ID: 16468656
[TBL] [Abstract][Full Text] [Related]
25. Decreased serum levels of transforming growth factor-beta1 in patients with autism.
Okada K; Hashimoto K; Iwata Y; Nakamura K; Tsujii M; Tsuchiya KJ; Sekine Y; Suda S; Suzuki K; Sugihara G; Matsuzaki H; Sugiyama T; Kawai M; Minabe Y; Takei N; Mori N
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):187-90. PubMed ID: 17030376
[TBL] [Abstract][Full Text] [Related]
26. Increased plasma levels of cystatin C and transforming growth factor-beta1 in patients with coronary artery ectasia: can there be a potential interaction between cystatin C and transforming growth factor-beta1.
Yetkin E; Acikgoz N; Sivri N; Tekin GO; Yagmur J; Aksoy Y; Turhan H
Coron Artery Dis; 2007 May; 18(3):211-4. PubMed ID: 17429295
[TBL] [Abstract][Full Text] [Related]
27. Effect of ulcerative colitis activity on plasma concentration of transforming growth factor beta1.
Wiercińska-Drapało A; Flisiak R; Prokopowicz D
Cytokine; 2001 Jun; 14(6):343-6. PubMed ID: 11497495
[TBL] [Abstract][Full Text] [Related]
28. Beta 2-microglobulin in patients with Balkan nephropathy and in healthy members of their families.
Stefanović V; Mitić-Zlatković M; Cukuranović R; Miljković P; Pavlović NM; Vlahović P
Kidney Int Suppl; 1991 Nov; 34():S21-6. PubMed ID: 1762327
[TBL] [Abstract][Full Text] [Related]
29. Enoxaparin but not unfractionated heparin causes a dose-dependent increase in plasma TGF-beta 1 during haemodialysis: a cross-over study.
Naumnik B; Borawski J; Pawlak K; Mysliwiec M
Nephrol Dial Transplant; 2007 Jun; 22(6):1690-6. PubMed ID: 17389624
[TBL] [Abstract][Full Text] [Related]
30. Conversion from calcineurin inhibitors to sirolimus in kidney transplant patients reduces the urinary transforming growth factor-beta1 concentration.
Saurina A; Campistol JM; Lario S; Oppenheimer F; Diekmann F
Transplant Proc; 2007 Sep; 39(7):2138-41. PubMed ID: 17889117
[TBL] [Abstract][Full Text] [Related]
31. Expression of transforming growth factor beta1 in patients with and without previous abdominal surgery.
Hobson KG; DeWing M; Ho HS; Wolfe BM; Cho K; Greenhalgh DG
Arch Surg; 2003 Nov; 138(11):1249-52. PubMed ID: 14609876
[TBL] [Abstract][Full Text] [Related]
32. The significance of serum transforming growth factor beta 1 in detecting of gastric and colon cancers.
Coban S; Yüksel O; Koçkar MC; Köklü S; Basar O; Tutkak H; Ormeci N
Hepatogastroenterology; 2007; 54(77):1472-6. PubMed ID: 17708279
[TBL] [Abstract][Full Text] [Related]
33. Implication of co-measured platelet factor 4 in the reliability of the results of the plasma transforming growth factor-beta 1 measurement.
Jeon JH; Kim YS; Choi EJ; Cheon S; Kim S; Kim JS; Jang JS; Ha WS; Park ST; Park CS; Park K; Park BK
Cytokine; 2001 Nov; 16(3):102-5. PubMed ID: 11741350
[TBL] [Abstract][Full Text] [Related]
34. Upper urothelial carcinoma in Balkan endemic nephropathy and non-endemic regions: a comparative study of pathological features.
Jankovic Velickovic L; Hattori T; Dolicanin Z; Visnjic M; Krstic M; Ilic I; Cukuranovic R; Rajic M; Stefanovic V
Pathol Res Pract; 2009; 205(2):89-96. PubMed ID: 19106018
[TBL] [Abstract][Full Text] [Related]
35. Plasma TGF-beta1 as a risk factor for gingival overgrowth.
Ellis JS; Morgan CL; Kirby JA; Taylor JJ; Thomason JM
J Clin Periodontol; 2004 Oct; 31(10):863-8. PubMed ID: 15367190
[TBL] [Abstract][Full Text] [Related]
36. Gingival crevicular fluid transforming growth factor-beta1 in cyclosporine and tacrolimus treated renal transplant patients without gingival overgrowth.
Gürkan A; Afacan B; Emingil G; Töz H; Başkesen A; Atilla G
Arch Oral Biol; 2008 Aug; 53(8):723-8. PubMed ID: 18342291
[TBL] [Abstract][Full Text] [Related]
37. Placental growth factor and placental protein 13 in patients with Balkan endemic nephropathy, a worldwide disease.
Stefanovic V; Cukuranovic R; Dolicanin Z; Cukuranovic J; Stojnev S; Bogdanovic D; Rajic M; Kocic G
Ren Fail; 2015 Aug; 37(7):1145-8. PubMed ID: 26133742
[TBL] [Abstract][Full Text] [Related]
38. [Serum TGF-beta1 level in children with reflux nephropathy].
Zajaczkowska M; Bieniaś B; Borzecka H; Sikora P; Majewski M; Bojarska-Junak A
Przegl Lek; 2006; 63 Suppl 3():121-3. PubMed ID: 16898507
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus infection and plasma transforming growth factor-beta1 levels in head and neck cancers.
Chen HW; Yang SF; Chang YC; Wang TY; Chen YJ; Hwang JJ
Acta Otolaryngol; 2008 Oct; 128(10):1145-51. PubMed ID: 18720060
[TBL] [Abstract][Full Text] [Related]
40. Change of plasma transforming growth factor-beta1 levels in nasopharyngeal carcinoma patients treated with concurrent chemo-radiotherapy.
Chen HW; Chang YC; Lai YL; Chen YJ; Huang MJ; Leu YS; Fu YK; Wang LW; Hwang JJ
Jpn J Clin Oncol; 2005 Aug; 35(8):427-32. PubMed ID: 16006572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
